HEALTH TECHNOLOGY ASSESSMENT (HTA)
- Affordability and sustainability. Difference between HTA and payer perspective. What is Europe’s challenge? How to influence reimbursement decisions as a patient advocate? | Author/Presenter: Zack Pemberton-Whiteley (Acute Leukaemia Network / Leukaemia Care UK) | Type: Slide presentation | Source: WECAN Academy Knowledge Base